ASIA unversity:Item 310904400/6759
English  |  正體中文  |  简体中文  |  全文笔数/总笔数 : 90429/105609 (86%)
造访人次 : 10283305      在线人数 : 97
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜寻范围 查询小技巧:
  • 您可在西文检索词汇前后加上"双引号",以获取较精准的检索结果
  • 若欲以作者姓名搜寻,建议至进阶搜寻限定作者字段,可获得较完整数据
  • 进阶搜寻
    ASIA unversity > 醫學暨健康學院 > 期刊論文 >  Item 310904400/6759


    题名: Discovery of potent inhibitors for phosphodiesterase 5 by virtual screening and pharmacophore analysis
    作者: Chien-yu CHEN;Yea-huey CHANG;Da-Tian Bau;Hung-jin HUANG;Fuu-Jen Tsai;Chang-Hai Tsai;Chen, Calvin Yu-Chian
    日期: 2009-08
    上传时间: 2009-12-23 14:22:06 (UTC+8)
    出版者: Asia University
    摘要: Aim: To explore the potent inhibitor from one of the Traditional Chinese medicine (TCM), Epimedium sagittatum.
    Methods: We predicted the potent compound, ES03b, de novo evolution from the four Epimedium sagittatum components were verified by molecular docking, pharmacophore analysis, and analysis of quantitative structure-activity relationship (QSAR) model, which was constructed by multiple linear regression.
    Results: ES03b was chosen to undergo drug modification via de novo evolution. By analyzing the pharmacophore features, we found that the hydrophobic core in the binding site and the hydrogen bond generated at Asn663 played key roles in designing PDE5 inhibitors. ES03b generated 49 diversities (Evo01-49). Evo48 had high activity in prediction. Although the value of prediction was overestimated, Evo48 was suggested as the potent lead.
    Conclusion: In this study, we showed that the hydrophobic core in the binding site and hydrogen bond production on Asn663 played key roles to design PDE5 inhibitors. From several require validation analysis, Evo48 was suggested to be a potent inhibitor.
    關聯: ACTA PHARMACOLOGICA SINICA 30 (8): 1186-1194
    显示于类别:[醫學暨健康學院] 期刊論文


    档案 描述 大小格式浏览次数
    268.doc39KbMicrosoft Word1358检视/开启


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回馈